NQ-1123

N/A

Report date: 2025/01/26 16:45:12
NME

Base Information

Drug NameNQ-1123
Drug Alias NameNQ-1123
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuroQuest Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuroQuest Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A